Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

Condition:   Malignant Neoplasm Interventions:   Drug: Decitabine;   Biological: DC-CIK Sponsor:   Li Yu Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials